Dr. Rampal is an Associate Member at Memorial Sloan-Kettering Cancer. He is Director of the MPN and Rare Hematologic Malignancies Program at MSK and also Director of the Center for Hematologic Malignancies at MSK.

The focus of his laboratory and clinical research has been elucidate mechanism of pathogenesis of the Philadelphia-chromosome negative Myeloproliferative Neoplasms (MPN) and to develop novel mechanism-based therapeutic approaches for MPNs.